These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 22532171)
21. Impulse control and related disorders in Parkinson's disease. Weintraub D; Nirenberg MJ Neurodegener Dis; 2013; 11(2):63-71. PubMed ID: 23038208 [TBL] [Abstract][Full Text] [Related]
22. [Hypersexuality and other impulse control disorders in Parkinson's disease]. Nelis EA; Berendse HW; van den Heuvel OA Ned Tijdschr Geneeskd; 2016; 160():A9359. PubMed ID: 26732226 [TBL] [Abstract][Full Text] [Related]
23. Drug-induced impulse control disorders: a review. Atmaca M Curr Clin Pharmacol; 2014 Feb; 9(1):70-4. PubMed ID: 24219002 [TBL] [Abstract][Full Text] [Related]
24. Depression as a Risk Factor for Impulse Control Disorders in Parkinson Disease. Marín-Lahoz J; Sampedro F; Martinez-Horta S; Pagonabarraga J; Kulisevsky J Ann Neurol; 2019 Nov; 86(5):762-769. PubMed ID: 31415102 [TBL] [Abstract][Full Text] [Related]
25. Dopaminergic influences on executive function and impulsive behaviour in impulse control disorders in Parkinson's disease. Leroi I; Barraclough M; McKie S; Hinvest N; Evans J; Elliott R; McDonald K J Neuropsychol; 2013 Sep; 7(2):306-25. PubMed ID: 23901888 [TBL] [Abstract][Full Text] [Related]
26. Screening for impulse control disorders in Parkinson's disease and dopamine agonist use: a study of pharmacokinetic and psychological risk factors. Contin M; Lopane G; Marini L; Mohamed S; Sambati L; De Massis P; Guarino M; Sermi S; Persichella C; Cortelli P; Calandra-Buonaura G Neurol Sci; 2023 Feb; 44(2):565-572. PubMed ID: 36350455 [TBL] [Abstract][Full Text] [Related]
27. Dopamine Agonists and Impulse Control Disorders: A Complex Association. Grall-Bronnec M; Victorri-Vigneau C; Donnio Y; Leboucher J; Rousselet M; Thiabaud E; Zreika N; Derkinderen P; Challet-Bouju G Drug Saf; 2018 Jan; 41(1):19-75. PubMed ID: 28861870 [TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics of impulse control and repetitive behavior disorders in Parkinson's disease. Kim J; Kim M; Kwon DY; Seo WK; Kim JH; Baik JS; Koh SB J Neurol; 2013 Feb; 260(2):429-37. PubMed ID: 22893307 [TBL] [Abstract][Full Text] [Related]
29. Impulse control and related behaviors in Parkinson's disease with dementia. Martinez-Martin P; Wan YM; Ray Chaudhuri K; Schrag AE; Weintraub D Eur J Neurol; 2020 Jun; 27(6):944-950. PubMed ID: 32048392 [TBL] [Abstract][Full Text] [Related]
30. Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists. Bienfait KL; Menza M; Mark MH; Dobkin RD J Clin Neurosci; 2010 Apr; 17(4):539-40. PubMed ID: 20171891 [TBL] [Abstract][Full Text] [Related]
31. Extrastriatal dopaminergic changes in Parkinson's disease patients with impulse control disorders. Lee JY; Seo SH; Kim YK; Yoo HB; Kim YE; Song IC; Lee JS; Jeon BS J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):23-30. PubMed ID: 24023269 [TBL] [Abstract][Full Text] [Related]
32. A Multicenter Comparative Study of Impulse Control Disorder in Latin American Patients With Parkinson Disease. Ramírez Gómez CC; Serrano Dueñas M; Bernal O; Araoz N; Sáenz Farret M; Aldinio V; Montilla V; Micheli F Clin Neuropharmacol; 2017; 40(2):51-55. PubMed ID: 28288482 [TBL] [Abstract][Full Text] [Related]
33. Long-term follow-up of impulse control disorders in Parkinson's disease. Mamikonyan E; Siderowf AD; Duda JE; Potenza MN; Horn S; Stern MB; Weintraub D Mov Disord; 2008 Jan; 23(1):75-80. PubMed ID: 17960796 [TBL] [Abstract][Full Text] [Related]
34. Characteristics of behavioural addiction in Parkinson's disease patients with self-reported impulse control disorder and controls matched for levodopa equivalent dose: a matched case-control study. Leplow B; Renftle D; Thomas M; Michaelis K; Solbrig S; Maetzler W; Berg D; Liepelt-Scarfone I J Neural Transm (Vienna); 2023 Feb; 130(2):125-133. PubMed ID: 36662280 [TBL] [Abstract][Full Text] [Related]
35. Impulse control disorder related behaviours during long-term rotigotine treatment: a post hoc analysis. Antonini A; Chaudhuri KR; Boroojerdi B; Asgharnejad M; Bauer L; Grieger F; Weintraub D Eur J Neurol; 2016 Oct; 23(10):1556-65. PubMed ID: 27425586 [TBL] [Abstract][Full Text] [Related]
36. The relationship between Impulse Control Disorders and cognitive dysfunctions in Parkinson's Disease: A meta-analysis. Santangelo G; Raimo S; Barone P Neurosci Biobehav Rev; 2017 Jun; 77():129-147. PubMed ID: 28242338 [TBL] [Abstract][Full Text] [Related]
37. Impulse Control Disorders in Parkinson's Disease. Weintraub D; Mamikonyan E Am J Psychiatry; 2019 Jan; 176(1):5-11. PubMed ID: 30848949 [No Abstract] [Full Text] [Related]
38. Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease. Smith KM; Xie SX; Weintraub D J Neurol Neurosurg Psychiatry; 2016 Aug; 87(8):864-70. PubMed ID: 26534930 [TBL] [Abstract][Full Text] [Related]
39. Wait and you shall see: sexual delay discounting in hypersexual Parkinson's disease. Girard R; Obeso I; Thobois S; Park SA; Vidal T; Favre E; Ulla M; Broussolle E; Krack P; Durif F; Dreher JC Brain; 2019 Jan; 142(1):146-162. PubMed ID: 30590514 [TBL] [Abstract][Full Text] [Related]